Encompass Health Financial Statements
NYSE: EHCHealth CareHospital/Nursing ManagementUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Encompass Health revenue and earnings
In fiscal 2025, Encompass Health generated $5.94 billion in revenue, up 10.5% from fiscal 2024, its 5th consecutive year of revenue growth. Net income was $566.2 million (+24.2% year over year), for a net margin of 9.5% versus a median of 8.0% in the prior 5 years. Diluted earnings per share came in at $5.54, up from $4.46.
Over the last 5 fiscal years, EHC's revenue has grown at a 10.7% compound annual rate.
Summary generated from market data by MetaCap's automated system. Methodology
Encompass Health income statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 5.94B | 5.37B | 4.80B | 4.35B | 4.01B | 3.57B | 4.61B | 4.28B | 3.91B | 3.64B |
| Revenue growth (YoY) | +10.46% | +11.91% | +10.41% | +8.31% | +12.58% | -22.56% | +7.66% | +9.28% | +7.45% | +15.17% |
| Operating Income | — | — | — | 539.50M | 559.60M | 563.90M | 612.10M | 555.20M | 578.30M | 588.10M |
| Interest Expense | 123.20M | 137.40M | 143.50M | 175.70M | 164.30M | 183.70M | 159.70M | 147.30M | 154.40M | 172.10M |
| Other Income (Expense) | 18.80M | 20.10M | 15.70M | -5.20M | 7.50M | 8.40M | 30.50M | 2.20M | 4.10M | 2.90M |
| Pretax Income | 953.00M | 749.60M | 607.20M | 450.80M | 505.00M | 352.90M | 562.30M | 493.20M | 496.40M | 482.00M |
| Income Tax | 192.90M | 150.20M | 132.20M | 100.10M | 101.90M | 74.70M | 115.90M | 118.90M | 145.80M | 163.90M |
| Net Income | 566.20M | 455.70M | 352.00M | 271.00M | 412.20M | 284.20M | 358.70M | 292.30M | 271.10M | 247.60M |
| Net Income growth (YoY) | +24.25% | +29.46% | +29.89% | -34.26% | +45.04% | -20.77% | +22.72% | +7.82% | +9.49% | +35.23% |
| EPS (Basic) | 5.62 | 4.53 | 3.51 | 2.72 | 4.15 | 2.87 | 3.65 | 2.98 | 2.88 | 2.77 |
| EPS (Diluted) | 5.54 | 4.46 | 3.47 | 2.70 | 4.11 | 2.85 | 3.61 | 2.93 | 2.84 | 2.59 |
| Shares Outstanding (Basic) | 100.50M | 99.90M | 99.50M | 99.20M | 99.00M | 98.60M | 98.00M | 97.90M | 93.70M | 89.10M |
| Shares Outstanding (Diluted) | 102.20M | 102.20M | 101.30M | 100.40M | 100.20M | 99.80M | 99.40M | 99.80M | 99.30M | 99.50M |
| EBITDA | — | — | — | 783.10M | 779.20M | 766.90M | 830.80M | 754.90M | 762.10M | 760.70M |
| Operating Margin | — | — | — | 12.41% | 13.94% | 15.81% | 13.29% | 12.98% | 14.78% | 16.15% |
| Net Margin | 9.54% | 8.48% | 7.33% | 6.23% | 10.27% | 7.97% | 7.79% | 6.83% | 6.93% | 6.80% |
This table shows 10 annual periods of Encompass Health's income statement, from FY 2025 back to FY 2016, across 14 line items including revenue, operating income, interest expense. Values in USD; B = billions, M = millions. Fiscal periods follow EHC's reporting calendar. What is a income statement?